Evidence map›Paper›PMID 31949854›Full record

ArticleInternational journal of clinical and experimental pathology2018

The protective effect of the Rho-kinase inhibitor hydroxyfasudil on propofol-induced hippocampal neuron apoptosis in neonatal rats.

Xuze Li, Lining Huang, Zhifang Zhao, Lijun Bo, Rongtian Kang, Jiaojiao Yang, Zhenming Dong

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xuze LiDepartment of Anesthesiology, The Second Hospital of Hebei Medical University Shijiazhuang, China.
Lining HuangDepartment of Anesthesiology, The Second Hospital of Hebei Medical University Shijiazhuang, China.
Zhifang ZhaoDepartment of Respiration, The Third Hospital of Hebei Medical University Shijiazhuang, China.
Lijun BoDepartment of Anesthesiology, The Second Hospital of Hebei Medical University Shijiazhuang, China.
Rongtian KangDepartment of Anesthesiology, The Second Hospital of Hebei Medical University Shijiazhuang, China.
Jiaojiao YangDepartment of Anesthesiology, The Second Hospital of Hebei Medical University Shijiazhuang, China.
Zhenming DongDepartment of Anesthesiology, The Second Hospital of Hebei Medical University Shijiazhuang, China.
Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propofol is widely applied for anesthesia induction in pediatric patients. However, accumulating evidence has proved that propofol is neurotoxic to the immature or developing brain. In the present study, we found that hydroxyfasudil, a specific inhibitor of Rho kinase, alleviated the apoptotic neurodegeneration induced by propofol in the developing rat brain. A spatial probe test and Morris water maze test revealed that hydroxyfasudil showed a potential improvement of the tendency towards cognitive impairments induced by propofol. Mechanistically, hydroxyfasudil markedly ameliorated the activation of RhoA and the expression of Rock1, Rock2, Bak, Bax, and Bad induced by propofol and rescued the expression of Bcl2 suppressed by propofol. Our findings suggest that hydroxyfasudil may serve as an effective agent to reduce the propofol-induced neurotoxic effects in pediatric medical procedures.

Indexed as

anesthesiaapoptosishippocampal neuronHydroxyfasudilpropofol

Identifiers

PMID31949854
PMCPMC6962995
OpenAlexW3008994700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.